The critical analyzers and laboratory equipment Federal Supply Schedule (FSS-66-III) contract awarded by the U.S. Department of Veterans Affairs (VA) to Abbott Laboratories Inc. has a potential value of up to $606 million over its April 2025 period of performance. This indefinite delivery/indefinite quantity (IDIQ) contract enables the VA to efficiently procure a wide range of diagnostic testing equipment, reagents, consumables, and related services from Abbott to support clinical laboratory operations at VA healthcare facilities nationwide.
The contract and associated delivery orders and blanket purchase agreements (BPAs) provide the VA access to Abbott's medical devices, such as chemistry and immunoassay analyzers, as well as testing supplies like reagents and controls. These solutions support patient care programs by ensuring reliable access to critical laboratory testing capabilities across the VA's regional Veterans Integrated Service Networks. The contracts leverage Abbott's expertise in diagnostics to streamline procurement and rapid fulfillment of the VA's requirements, without the use of any set-aside designations. Key performance locations include Abbott's facilities in North Chicago, Illinois, as well as on-site at VA medical centers.
Generated 9/7/24, 11:15 AM